Skip to main content
OpenTrials

Clinical trial condition

Lung Diseases, Obstructive

Explore clinical trials studying Lung Diseases, Obstructive. Study availability and eligibility vary by location and protocol.

7,975 public trials 742 recruiting studies
Refine in advanced search Browse all conditions

Lung Diseases, Obstructive trial results

Completed

Safety And Efficacy Of GSK233705 Plus Salmeterol Compared With 2 Active Comparators And Placebo In Subjects With Chronic Obstructive Pulmonary Disease (COPD)

NCT00422604

Conditions
Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations
  • GSK Investigational Site Helsinki, Finland
  • GSK Investigational Site Wiesbaden, Hesse, Germany
  • GSK Investigational Site Großhansdorf, Schleswig-Holstein, Germany
  • GSK Investigational Site Almelo, Netherlands
View Trial Details
Completed

Symbicort Turbuhaler 30/60 Special Clinical Experience Investigation for Long-term Use for Chronic Obstructive Pulmonary Disease (COPD) Patients

NCT01713075

Conditions
Chronic Disease, Chronic Obstructive Pulmonary Disease, Disease Attributes, +6 more
Locations
  • Research Site Aichi, Japan
  • Research Site Akita, Japan
  • Research Site Aomori, Japan
  • Research Site Chiba, Japan
View all 47 locations
View Trial Details
Completed

Study Of Patients With Allergic Rhinitis And Asthma

NCT00296530

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +10 more
Locations
  • GSK Investigational Site Ozark, Alabama, United States
  • GSK Investigational Site Tempe, Arizona, United States
  • GSK Investigational Site Little Rock, Arkansas, United States
  • GSK Investigational Site Fountain Valley, California, United States
View all 80 locations
View Trial Details
Completed

Study In Subjects With COPD (Chronic Obstructive Pulmonary Disease)

NCT00103922

Conditions
Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations
  • GSK Investigational Site Birmingham, Alabama, United States
  • GSK Investigational Site Jasper, Alabama, United States
  • GSK Investigational Site Phoenix, Arizona, United States
  • GSK Investigational Site Tempe, Arizona, United States
View all 115 locations
View Trial Details
Completed

ADVAIR® DISKUS® Inhaler (Fluticasone Propionate/Salmeterol) Versus SEREVENT® DISKUS® Inhaler (Salmeterol) For The Treatment Of Chronic Obstructive Pulmonary Disease Exacerbations. ADVAIR® DISKUS® Inhaler and SEREVENT® DISKUS® Inhaler Are Trademarks of the GSK Group of Companies.

NCT00144911

Conditions
Chronic Disease, Disease Attributes, Lung Diseases, +7 more
Locations
  • GSK Investigational Site Birmingham, Alabama, United States
  • GSK Investigational Site Birmingham, Alabama, United States
  • GSK Investigational Site Jasper, Alabama, United States
  • GSK Investigational Site Glendale, Arizona, United States
View all 97 locations
View Trial Details

Related conditions